Notifying Changes To Marketed Devices In Singapore Becomes Easier From Dec. 1
This article was originally published in SRA
Singapore's Health Sciences Authority has adopted a revised policy that will make it easier for medical device companies to notify the agency of any changes they make concerning a marketed device1,2. The revised policy, issued in the form of an updated guidance, will apply to "change notification" applications submitted by companies as of Dec. 1 when the policy comes into effect.
You may also be interested in...
A new draft guideline explains how sponsors of subsequent-entry orally inhaled drug products can comply with the Canadian requirement for demonstrating equivalence to the reference product.
While good clinical practice inspectors in the UK and the US collaborate on matters of common interest, they say that mutual recognition is simply not possible.
Whoever takes over as chair of the Medicines and Healthcare products Regulatory Agency will play a key role in its plans to deliver a program of “ambitious business change.”